Description
Developer of stem cells. The company is engaged in the research and development of stem cells from the amniotic membrane of the umbilical cord for stem cell regenerative medicine and therapy.
Contact Information
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2020362379-A1 | A method of assessing wound healing potency of a mesenchymal stem population and related methods of selecting mesenchymal stem cells and identifying tissue as starting material for producing a mesenchymal stem cell population | Pending | 08-Oct-2019 | 00000000000 | |
CA-3151737-A1 | A method of assessing wound healing potency of a mesenchymal stem population and related methods of selecting mesenchymal stem cells and identifying tissue as starting material for producing a mesenchymal stem cell population | Pending | 08-Oct-2019 | 00000000000 | |
EP-4042157-A1 | A method of assessing wound healing potency of a mesenchymal stem population and related methods of selecting mesenchymal stem cells and identifying tissue as starting material for producing a mesenchymal stem cell population | Pending | 08-Oct-2019 | 00000000000 | |
US-20210140942-A1 | Method of assessing wound healing potency of a mesenchymal stem population and related methods of selecting mesenchymal stem cells and identifying tissue as starting material for producing a mesenchymal stem cell population | Pending | 08-Oct-2019 | 00000000000 | 0 |
US-20210301252-A9 | Method of inducing or improving wound healing properties of mesenchymal stem cells | Pending | 12-Apr-2018 | C12N5/0605 |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Gavin Tan | Chief Executive Officer | ||
Edwin Chow | Chief Operating Officer & Business Manager | ||
Yvonne Chan | Director |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|